Abstract:Background Rapid proliferation and glucose metabolism remodeling are hallmarks of cancers. Long non-coding RNAs (lncRNAs) are potentially involved in Warburg effect. We aimed to identify oncogenic lncRNAs that significantly affect the development of esophageal squamous cell carcinoma (ESCC) and investigate the metabolism-related mechanisms. Methods Bioinformatics analysis and siRNA library screening were used to pinpoint lncRNAs that significantly affected cell glycolysis and proliferation. RNAScope(R) in situ hybridization and qRT-PCR assays were performed in clinical samples to investigate expression levels and clinical relevance of the lncRNA. RNA interference and CRISPR-Cas9 were used to explore the functional roles of the lncRNA. In vivo, cell-based and patient-derived xenograft (PDX) models were used. Extracellular acidification rate and 13C-labeled intracellular metabolites were determined. RNA pull-down, MS2-Tagged RNA affinity purification, RNA-binding protein immunoprecipitation and cross-linking immunoprecipitation were performed to identify lncRNA associated proteins and related mechanisms. Results The lncRNA LOC148709 was identified as a metabolism-related lncRNA. Increased expression of LOC148709 was observed in ESCC and was correlated with poor prognosis. LOC148709 knockdown significantly decreased cell proliferation and glycolysis. Mechanistically, LOC148709 was directly associated with PFKFB3 and significantly affected PFKFB3 stability. LOC148709 interacted mainly with the C-terminal fragment of PFKFB3 and the T5 (2031–2321) fragment of LOC148709 mediated the interaction with PFKFB3. Through inhibiting K302 ubiquitination, LOC148709 protected PFKFB3 from proteasomal degradation, which subsequently activated glycolytic flux and promoted cell cycle progression by regulating p27 and CDK1. P53 could bind to the LOC148709 promoter and repress its transcription, p53 loss or mutation triggered striking LOC148709 upregulation. Multiple micro-environmental factors, including hypoxia and oncogenic stress, were also involved in the LOC148709 regulatory network via affecting the status of p53. Notably, our patient-derived xenograft (PDX) model studies demonstrated that LOC148709 knockdown dramatically impaired tumor growth. Conclusions The lncRNA LOC148709 plays an essential role in glycolytic reprogramming by binding to and stabilizing PFKFB3. This study identified a novel metabolism-related lncRNA and revealed a novel mechanism underlying lncRNA-mediated cancer metabolism remodeling. Translational studies further implicated that LOC148709 is a promising biomarker for cancer diagnosis and therapy.

PO-364 LncRNA-P23154 Promotes the Invasion-Metastasis Potential of Oral Squamous Cell Carcinoma by Regulating Glut1-mediated Glycolysis

Abstract 2389: LINC00901 Regulates Glucose Metabolism in Pancreatic Cancer

Linc00901 Regulates Glucose Metabolism In Pancreatic Cancer.

Long Non-Coding RNA LINC01296 Promotes Progression of Oral Squamous Cell Carcinoma Through Activating the MAPK/ERK Signaling Pathway Via the Mir-485-5p/pak4 Axis

LncRNA PVT1 influences breast cancer cells glycolysis through sponging miR-145-5p

Long Noncoding RNA AGPG Regulates PFKFB3-mediated Tumor Glycolytic Reprogramming

Long non-coding RNA SLC2A1-AS1 induced by GLI3 promotes aerobic glycolysis and progression in esophageal squamous cell carcinoma by sponging miR-378a-3p to enhance Glut1 expression

LINC01116 Promotes Migration and Invasion of Oral Squamous Cell Carcinoma by Acting as a Competed Endogenous RNA in Regulation of MMP1 Expression

LINC00152 Promotes the Growth and Invasion of Oral Squamous Cell Carcinoma by Regulating Mir-139-5p.

LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway

IDDF2019-ABS-0200 Long Non-Coding RNA LOC148709 Regulates PFKFB3-mediated Glycolytic Reprogramming in Esophageal Squamous Cell Carcinoma

LncOCMRL1 promotes oral squamous cell carcinoma growth and metastasis via the RRM2/EMT pathway

Cmar_a_298236 1831..1841

lncRNA MALAT1 promotes cell proliferation and invasion by regulating the miR-101/EZH2 axis in oral squamous cell carcinoma

LINC00941 Promotes Glycolysis in Pancreatic Cancer by Modulating the Hippo Pathway

LINC01315 Impairs microRNA-211-Dependent DLG3 Downregulation to Inhibit the Development of Oral Squamous Cell Carcinoma

Silencing of LncRNA SNHG16 Downregulates Cyclin D1 (CCND1) to Abrogate Malignant Phenotypes in Oral Squamous Cell Carcinoma (OSCC) Through Upregulating Mir-17-5p

LINC00035 Transcriptional Regulation of SLC16A3 via CEBPB Affects Glycolysis and Cell Apoptosis in Ovarian Cancer

LncRNA LINC00689 Promotes the Growth, Metastasis and Glycolysis of Glioma Cells by Targeting Mir-338-3p/pkm2 Axis.

IDDF2018-ABS-0184 LNCRNA AGPG Regulates Anabolism Remodelling Through Affecting PFKFB3 Stability in Escc

Long non-coding RNA LINC01207 promotes cell proliferation and migration but suppresses apoptosis and autophagy in oral squamous cell carcinoma by the microRNA-1301-3p/lactate dehydrogenase isoform A axis